We narrowed to 101 results for: mak
- 
  Viral Prep#26969-AAV5PurposeReady-to-use AAV5 particles produced from pAAV-CaMKIIa-hChR2(H134R)-EYFP (#26969). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-EYFP plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIITagsEYFPAvailable SinceMarch 7, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-CaMKIIa-hChR2(H134R)-EYFP (AAV9)Viral Prep#26969-AAV9PurposeReady-to-use AAV9 particles produced from pAAV-CaMKIIa-hChR2(H134R)-EYFP (#26969). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-EYFP plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIITagsEYFPAvailable SinceMarch 7, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-Ef1a-DIO eNpHR 3.0-EYFP (AAV1)Viral Prep#26966-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-Ef1a-DIO eNpHR 3.0-EYFP (#26966). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO eNpHR 3.0-EYFP plasmid DNA. EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aTagsEYFP (Cre-dependent)Available SinceFeb. 14, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-Ef1a-DIO eNpHR 3.0-EYFP (AAV5)Viral Prep#26966-AAV5PurposeReady-to-use AAV5 particles produced from pAAV-Ef1a-DIO eNpHR 3.0-EYFP (#26966). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO eNpHR 3.0-EYFP plasmid DNA. EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aTagsEYFP (Cre-dependent)Available SinceFeb. 14, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-Ef1a-DIO eNpHR 3.0-EYFP (AAV9)Viral Prep#26966-AAV9PurposeReady-to-use AAV9 particles produced from pAAV-Ef1a-DIO eNpHR 3.0-EYFP (#26966). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO eNpHR 3.0-EYFP plasmid DNA. EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aTagsEYFP (Cre-dependent)Available SinceApril 6, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-CaMKIIa-hChR2(H134R)-EYFP (AAV1)Viral Prep#26969-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-CaMKIIa-hChR2(H134R)-EYFP (#26969). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-EYFP plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIITagsEYFPAvailable SinceMay 9, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-hSyn-mScarlet (AAV1)Viral Prep#131001-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-hSyn-mScarlet (#131001). In addition to the viral particles, you will also receive purified pAAV-hSyn-mScarlet plasmid DNA. Synapsin-driven mScarlet control vector. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsmScarletAvailable SinceNov. 29, 2021AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-CaMKIIa-hChR2(H134R)-EYFP (AAV2)Viral Prep#26969-AAV2PurposeReady-to-use AAV2 particles produced from pAAV-CaMKIIa-hChR2(H134R)-EYFP (#26969). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-EYFP plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIITagsEYFPAvailable SinceFeb. 14, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-hSyn-mScarlet (AAV8)Viral Prep#131001-AAV8PurposeReady-to-use AAV8 particles produced from pAAV-hSyn-mScarlet (#131001). In addition to the viral particles, you will also receive purified pAAV-hSyn-mScarlet plasmid DNA. Synapsin-driven mScarlet control vector. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsmScarletAvailable SinceSept. 27, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-CaMKIIa-mScarlet (AAV8)Viral Prep#131000-AAV8PurposeReady-to-use AAV8 particles produced from pAAV-CaMKIIa-mScarlet (#131000). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-mScarlet plasmid DNA. CamKIIa-driven expression of mScarlet. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIITagsmScarletAvailable SinceSept. 27, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-CaMKIIa-Flpo (AAV8)Viral Prep#183535-AAV8PurposeReady-to-use AAV8 particles produced from pAAV-CaMKIIa-Flpo (#183535). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-Flpo plasmid DNA. CamKIIa-driven expression of Flpo recombinase. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIIAvailable SinceOct. 8, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (AAV8)Viral Prep#61592-AAV8PurposeReady-to-use AAV8 particles produced from pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (#61592). In addition to the viral particles, you will also receive purified pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA plasmid DNA. CMV-driven expression of SaCas9. These AAV preparations are suitable purity for injection into animals.DepositorAvailable SinceSept. 22, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (AAV6)Viral Prep#61592-AAV6PurposeReady-to-use AAV6 particles produced from pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (#61592). In addition to the viral particles, you will also receive purified pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA plasmid DNA. CMV-driven expression of SaCas9. These AAV preparations are suitable purity for injection into animals.DepositorAvailable SinceJuly 16, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-EF1a-Flpo (AAV1)Viral Prep#55637-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-EF1a-Flpo (#55637). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flpo plasmid DNA. EF1a-driven Flpo recombinase expression. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aAvailable SinceJuly 8, 2019AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-Ef1a-DIO mScarlet (AAV1)Viral Prep#131002-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-Ef1a-DIO mScarlet (#131002). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO mScarlet plasmid DNA. EF1a-driven, Cre-dependent mScarlet expression. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aTagsmScarlet (Cre-dependent)Available SinceNov. 29, 2021AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-EF1a-Cre (AAV11)Viral Prep#55636-AAV11PurposeReady-to-use AAV11 particles produced from pAAV-EF1a-Cre (#55636). In addition to the viral particles, you will also receive purified pAAV-EF1a-Cre plasmid DNA. EF1a-driven expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aAvailable SinceJuly 16, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-Ef1a-DIO mScarlet (AAV5)Viral Prep#131002-AAV5PurposeReady-to-use AAV5 particles produced from pAAV-Ef1a-DIO mScarlet (#131002). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO mScarlet plasmid DNA. EF1a-driven, Cre-dependent mScarlet expression. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aTagsmScarlet (Cre-dependent)Available SinceSept. 27, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-EF1a-Flpo (AAV2)Viral Prep#55637-AAV2PurposeReady-to-use AAV2 particles produced from pAAV-EF1a-Flpo (#55637). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flpo plasmid DNA. EF1a-driven Flpo recombinase expression. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aAvailable SinceMarch 18, 2024AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (AAV9)Viral Prep#35499-AAV9PurposeReady-to-use AAV9 particles produced from pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (#35499). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP plasmid DNA. CaMKIIa-driven, C1V1 (t/t) fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIITagsEYFPAvailable SinceApril 6, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV.hSyn1.Twitch2B.WPRE.SV40 (AAV1)Viral Prep#100040-AAV1PurposeReady-to-use AAV1 particles produced from pAAV.hSyn1.Twitch2B.WPRE.SV40 (#100040). In addition to the viral particles, you will also receive purified pAAV.hSyn1.Twitch2B.WPRE.SV40 plasmid DNA. Synapsin-driven expression of (FRET)-based calcium biosensor Twitch2B. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynAvailable SinceMarch 8, 2018AvailabilityAcademic Institutions and Nonprofits only